细胞色素P450 3A、孕酮受体基因多态性、血浆17-α羟孕酮己酸酯浓度与自发性早产的关系
该二次分析纳入268例有自发性早产史并接受17-α羟孕酮己酸酯治疗的孕妇,评估CYP3A4、CYP3A5及孕酮受体单核苷酸多态性与血浆药物浓度及自发性早产的关系。CYP多态性与药物浓度无关,孕酮受体多态性与早产频率无关,低 trough 浓度与更高的自发性早产频率相关,但孕酮受体多态性未显著改变该关联。
要点
- CYP3A4*22、*1G、*1B和CYP3A5*3与17-α羟孕酮己酸酯 trough 浓度无显著关联。
- 孕酮受体 rs578029、rs471767、rs666553、rs503362、rs500760 与自发性早产频率无关。
- 低 trough 浓度与更高自发性早产频率相关(OR 0.78),但孕酮受体多态性未显著改变此关联。
核心结论
- 复发性自发性早产的频率似乎与17-α羟孕酮己酸酯的 trough 血浆浓度相关。
- trough 血浆浓度的广泛变异不能归因于CYP3A4和CYP3A5基因多态性。
- 孕酮受体多态性不能预测17-α羟孕酮己酸酯的疗效。
研究设计与样本
- 二次分析,纳入268例有自发性早产史并接受17-α羟孕酮己酸酯治疗的孕妇,这些孕妇参与了一项评估omega-3补充获益的安慰剂对照试验。
- 在妊娠25-28周、至少注射5次17-α羟孕酮己酸酯后测量 trough 血浆浓度。
- 从母血样本提取DNA,用TaqMan法对CYP3A4*1B、CYP3A4*1G、CYP3A4*22、CYP3A5*3及孕酮受体rs578029、rs471767、rs666553、rs503362、rs500760进行基因分型。
- 多变量分析中调整孕前体重指数、种族和治疗组。
主要发现
- CYP多态性*22、*1G、*1B和*3与17-α羟孕酮己酸酯 trough 血浆浓度的关联无统计学显著性(P值分别为.68、.44、.08和.44)。
- 调整后logistic回归模型中,孕酮受体多态性rs578029、rs471767、rs666553、rs503362和rs500760与自发性早产频率无关(P值分别为.29、.10、.76、.09和.43)。
- 低 trough 血浆浓度与更高的自发性早产频率有统计学关联(比值比0.78;95%置信区间0.61-0.99;四分位数趋势P=.04)。
- 未观察到与孕酮受体多态性rs578029、rs471767、rs666553、rs503362和rs500760的显著交互作用(P值分别为.13、.08、.10、.08和.13)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 该二次分析样本量相对较小(n=268)。
- 种族由患者自我报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infants born <37 weeks' gestation are of public health concern since complications associated with preterm birth are the leading cause of mortality in children <5 years of age and a major cause of morbidity and lifelong disability. The administration of 17-alpha hydroxyprogesterone caproate reduces preterm birth by 33% in women with history of spontaneous preterm birth. We demonstrated previously that plasma concentrations of 17-alpha hydroxyprogesterone caproate vary widely among pregnant women and that women with 17-alpha hydroxyprogesterone caproate plasma concentrations in the lowest quartile had spontaneous preterm birth rates of 40% vs rates of 25% in those women with higher concentrations. Thus, plasma concentrations are an important factor in determining drug efficacy but the reason 17-alpha hydroxyprogesterone caproate plasma concentrations vary so much is unclear. Predominantly, 17-alpha hydroxyprogesterone caproate is metabolized by CYP3A4 and CYP3A5 enzymes. OBJECTIVE: We sought to: (1) determine the relation between 17-alpha hydroxyprogesterone caproate plasma concentrations and single nucleotide polymorphisms in CYP3A4 and CYP3A5; (2) test the association between progesterone receptor single nucleotide polymorphisms and spontaneous preterm birth; and (3) test whether the association between plasma concentrations of 17-alpha hydroxyprogesterone caproate and spontaneous preterm birth varied by progesterone receptor single nucleotide polymorphisms. STUDY DESIGN: In this secondary analysis, we evaluated genetic polymorphism in 268 pregnant women treated with 17-alpha hydroxyprogesterone caproate, who participated in a placebo-controlled trial to evaluate the benefit of omega-3 supplementation in women with history of spontaneous preterm birth. Trough plasma concentrations of 17-alpha hydroxyprogesterone caproate were measured between 25-28 weeks of gestation after a minimum of 5 injections of 17-alpha hydroxyprogesterone caproate. We extracted DNA from maternal blood samples and genotyped the samples using TaqMan (Applied Biosystems, Foster City, CA) single nucleotide polymorphism genotyping assays for the following single nucleotide polymorphisms: CYP3A4*1B, CYP3A4*1G, CYP3A4*22, and CYP3A5*3; and rs578029, rs471767, rs666553, rs503362, and rs500760 for progesteronereceptor. We adjusted for prepregnancy body mass index, race, and treatment group in a multivariable analysis. Differences in the plasma concentrations of 17-alpha hydroxyprogesterone caproate by genotype were evaluated for each CYP single nucleotide polymorphism using general linear models. The association between progesterone receptor single nucleotide polymorphisms and frequency of spontaneous preterm birth was tested using logistic regression. A logistic model also tested interaction between 17-alpha hydroxyprogesterone caproate concentrations with each progesterone receptor single nucleotide polymorphism for the outcome of spontaneous preterm birth. RESULTS: The association between CYP single nucleotide polymorphisms *22, *1G, *1B, and *3 and trough plasma concentrations of 17-alpha hydroxyprogesterone caproate was not statistically significant (P = .68, .44, .08, and .44, respectively). In an adjusted logistic regression model, progesterone receptor single nucleotide polymorphisms rs578029, rs471767, rs666553, rs503362, and rs500760 were not associated with the frequency of spontaneous preterm birth (P = .29, .10, .76, .09, and .43, respectively). Low trough plasma concentrations of 17-alpha hydroxyprogesterone caproate were statistically associated with a higher frequency of spontaneous preterm birth (odds ratio, 0.78; 95% confidence ratio, 0.61-0.99; P = .04 for trend across quartiles), however no significant interaction with the progesterone receptor single nucleotide polymorphisms rs578029, rs471767, rs666553, rs503362, and rs500760 was observed (P = .13, .08, .10, .08, and .13, respectively). CONCLUSION: The frequency of recurrent spontaneous preterm birth appears to be associated with trough 17-alpha hydroxyprogesterone caproate plasma concentrations. However, the wide variation in trough 17-alpha hydroxyprogesterone caproate plasma concentrations is not attributable to polymorphisms in CYP3A4 and CYP3A5 genes. Progesterone receptor polymorphisms do not predict efficacy of 17-alpha hydroxyprogesterone caproate. The limitations of this secondary analysis include that we had a relative small sample size (n = 268) and race was self-reported by the patients.
引用
- Bustos ML, Caritis SN, Jablonski KA, et al. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth. Am J Obstet Gynecol. 2017. PMID: 28522317. doi:10.1016/j.ajog.2017.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。